INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Evolus, Inc. - EOLSPRNewsWire • Thursday
Evolus to Participate in Upcoming Investor Conferences in New York and LondonBusiness Wire • Wednesday
Evolus Expands Innovation Pipeline with Novel Injectable Hair Restoration ProgramBusiness Wire • 10/14/26
EOLS Investors with $100,000 in Losses Have Opportunity to Join Evolus, Inc. Fraud Investigation with SBS LawBusiness Wire • 10/12/26
Evolus Launches Wings by Evolus, a New Charitable Platform to Mobilize Its Community in Support of Important CausesBusiness Wire • 10/01/26
Wall Street Analysts Think Evolus (EOLS) Could Surge 77.68%: Read This Before Placing a BetZacks Investment Research • 08/27/26
Wall Street Analysts Believe Evolus (EOLS) Could Rally 106.08%: Here's is How to TradeZacks Investment Research • 08/11/26
Evolus Reports Strong Second Quarter 2026 Financial Results; Delivers Third Consecutive Quarter of Positive Adjusted EBITDA and Raises Full-Year 2026 Financial OutlookBusiness Wire • 08/05/26
Evolus Expands Strategic Partnership with Symatese to Commercialize Estyme® in Canada, Australia, and New ZealandBusiness Wire • 08/04/26
Evolus Announces Partnership with IBSA to Develop and Commercialize Market-Leading Profhilo® in the United States, Expanding Its Injectable Portfolio into Skin QualityBusiness Wire • 07/08/26
Evolus Announces Commercial Launch of Estyme® Injectable Hyaluronic Acid Gels in EuropeBusiness Wire • 05/11/26
Evolus Reports First Quarter 2026 Financial Results; Company Delivers Second Consecutive Quarter of Positive Adjusted EBITDA and Reaffirms Full-Year OutlookBusiness Wire • 05/04/26